Skip to main content

Table 2 Hematological and blood biochemical measurements of the 71 age-matched pediatric IA and COVID-19 patient pairsa

From: Comparison of clinical features on admission between coronavirus disease 2019 and influenza a among children: a retrospective study in China

  IA COVID-19 P
Blood routine(n = 59)
 Lymphocytes
  Count(×109/L) 1.8 (1.0–3.4) 3.2 (1.8–5.0) < 0.01
  Percentage (%) 26.0 (12.0–44.0) 50.4 (36.6–68.6) < 0.01
 Neutrophils
  Count (×109/L) 4.2 (2.8–7.7) 2.2 (1.4–4.1) < 0.01
  Percentage (%) 62.0 (43.0–78.0) 37.7 (21.5–49.1) < 0.01
 Hemoglobin (g/L) 112.0 (101.0–123.0) 123.0 (111.0–128.0) < 0.01
 Neutrophil-to-lymphocyte ratio 2.6 (0.9–7.1) 0.7 (0.3–1.4) < 0.01
Coagulation function(n = 51)
 Activated partial thromboplastin time (s) 42.4 (38.7–46.3) 35.2 (30.9–40.5) < 0.01
 Prothrombin time (s) 14.0 (12.7–15.1) 11.6 (10.7–12.8) < 0.01
Blood biochemistry
 Albumin (g/L) (n = 61) 42.0 (39.9–43.6) 44.2 (42.1–46.7) < 0.01
 C-reactive protein (mg/L) (n = 61) 5.8 (1.2–20.6) 0.9 (0.8–5.0) < 0.01
 Procalcitonin (ng/mL) (n = 44) 0.4 (0.2–1.0) 0.1 (0.1–0.1) < 0.01
  1. aFor each measurement, the exact number of patient pairs included in the analysis varied due to missing values. Distribution of the measurements is denoted by median and interquartile range (in parentheses). The P values were calculated using Wilcoxon signed-rank test
  2. Abbreviations: COVID-19 coronavirus disease 19, IA influenza A